Amarin Price to Book Ratio 2006-2021 | AMRN

Historical price to book ratio values for Amarin (AMRN) over the last 10 years. The current price to book ratio for Amarin as of October 15, 2021 is 3.16.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amarin Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-15 5.16 3.16
2021-06-30 4.38 $1.63 2.68
2021-03-31 6.21 $1.61 3.86
2020-12-31 4.89 $1.60 3.06
2020-09-30 4.21 $1.56 2.70
2020-06-30 6.92 $1.56 4.43
2020-03-31 4.00 $1.62 2.47
2019-12-31 21.44 $1.69 12.69
2019-09-30 15.16 $1.67 9.10
2019-06-30 19.39 $0.45 43.09
2019-03-31 20.76 $0.43 48.72
2018-12-31 13.61 $0.47 29.11
2018-09-30 16.27 $-0.17 -93.67
2018-06-30 3.09 $-0.16 -19.46
2018-03-31 3.01 $-0.06 -53.09
2017-12-31 4.01 $-0.24 -16.69
2017-09-30 3.50 $-0.17 -20.50
2017-06-30 4.03 $-0.14 -28.14
2017-03-31 3.20 $-0.11 -30.10
2016-12-31 3.08 $-0.03 -91.67
2016-09-30 3.19 $0.06 56.56
2016-06-30 2.16 $-0.89 -2.42
2016-03-31 1.53 $-0.85 -1.81
2015-12-31 1.89 $-0.70 -2.72
2015-09-30 1.93 $-0.61 -3.18
2015-06-30 2.46 $-0.50 -4.93
2015-03-31 2.34 $-0.35 -6.70
2014-12-31 0.98 $-0.51 -1.93
2014-09-30 1.09 $-0.40 -2.75
2014-06-30 1.76 $-0.29 -6.09
2014-03-31 1.81 $-0.33 -5.43
2013-12-31 1.97 $-0.20 -10.05
2013-09-30 6.32 $-0.10 -61.66
2013-06-30 5.80 $-0.63 -9.27
2013-03-31 7.41 $-0.40 -18.58
2012-12-31 8.09 $-0.03 -304.14
2012-09-30 12.58 $0.00 41916.67
2012-06-30 14.46 $0.04 402.79
2012-03-31 11.32 $-0.47 -23.97
2011-12-31 7.49 $-0.04 -170.62
2011-09-30 9.20 $-0.22 -41.18
2011-06-30 14.43 $-1.16 -12.42
2011-03-31 7.30 $-0.37 -19.83
2010-12-31 8.20 $-1.89 -4.33
2010-09-30 2.58 0.00
2010-06-30 2.49 0.00
2010-03-31 1.52 0.00
2009-12-31 1.43 0.00
2008-12-31 0.71 0.00
2008-06-30 1.89 0.00
2008-03-31 2.74 0.00
2007-12-31 2.60 0.00
2007-09-30 4.00 0.00
2007-06-30 5.90 0.00
2007-03-31 23.00 0.00
2006-12-31 22.80 0.00
2006-09-30 26.60 0.00
2006-06-30 23.90 0.00
2006-03-31 31.70 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.040B $0.614B
Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00